| Autor: |
Kalra, Sanjay, Unnikrishnan, A. G., Baruah, Manash, Kawatra, Pallavi, Ved, Jignesh |
| Předmět: |
|
| Zdroj: |
Indian Journal of Endocrinology & Metabolism; Sep/Oct2017, Vol. 21 Issue 5, p762-764, 3p |
| Abstrakt: |
Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize the pharmaco-ergonomic considerations for these agents, in the form of an SGLT2-i qualification tool, based on a clinical score. This tool may serve as a simple and inexpensive practical guide, to optimize the risk-benefit considerations for SGLT2-i agents. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
